Table 3. Survival prediction models according to stage.
| Harrel’s c | ASA=3 | BMP3 | BNC1 | GSTP1 | MESTv2 | MGMT | NPTX2 | SFRP1 | SFRP2 | TFPI2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All patients* | 0.73 | HR 95% CI | 3.34 (1.91-5.84) |
2.00 (1.26-3.18) |
9.55 (2.70-33.82) |
1.94 (1.24-3.02) |
0.45 (0.27-0.73) |
2.52 (1.42-4.47) |
||||
| Stage I, II** | 0.75 | HR 95% CI | 14.13 (4.56-43.81) |
2.39 (0.97-5.94) |
0.18 (0.07-0.45) |
|||||||
| Stage IV** | 0.71 | HR 95% CI | 2.65 (1.11-6.29) |
2.11 (0.57-7.87) |
0.45 (0.17-1.18) |
2.77 (1.15-6.67) |
Survival prediction models developed by multivariable Cox regression analysis using backward stepwise selection.
*Survival prediction model for the total group of patients with pancreatic adenocarcinoma without taking stage into account.
**Stage specific survival prediction model.
HR: Hazard ratio
CI: Confidence interval
ASA: American Society of Anesthesiologists score.
Note: Stage is in accordance with The American Joint Committee on Cancer stage classification.